CDMO Blog

close

Categories

See More

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
Understanding the Role of the Quality Unit in Good Manufacturing Practices
The Canadian Regulatory System for Cell and Gene Therapies
Planning Is Everything - Quality Control Testing in Cell and Gene Therapy
21 Sep 2022

Top 3 Trends in Cell and Gene Therapy

Thanks in part to lessons learned and trends accelerated by COVID-19, ...

18 Aug 2022

Top 6 Tips to Speed Up Manufacturing Your CGT Product

Managing the manufacturing process for cell and gene therapy (CGT) pro...

05 Jul 2022

Scaling-up Versus Scaling-out: Here’s What You Need To Know

A lot of CDMO customers ask about scale-out and scale-up, and what app...

24 Sep 2021

Tips for Managing GMP Manufacturing Timelines

Managing timelines is a shared challenge for contract development and ...

12 May 2021

How CCRM's Unique Approach Enables Client Success

Outsourcing to a contract development and manufacturing organization (...

20 Jan 2021

Solving the Technical Challenges in Gene Editing of Induced Pluripotent Stem Cells

In a previous post we provided an overview of induced pluripotent stem...

17 Dec 2020

Five Tips to Help Maximize Your Cell and Gene Therapy Budget

Developing cell and gene therapies (CGTs), from discovery to commercia...

11 Dec 2020

4 Tips from the Experts: How to Tighten Your Timeline from Development to Trial

Responsibly moving a cell or gene therapy forward as quickly as possib...

10 Jan 2020

Road to success: Understanding Good Laboratory Practice for cell and gene therapies

Good Laboratory Practice (GLP) studies are essential for generating no...

30 Oct 2019

Considerations for the Use of Stable Producer Lines in the Manufacturing of Lentiviral Vectors

In an introductory post on lentiviral vector (LVV) manufacturing for c...

22 Oct 2019

How Can a Contract Development and Manufacturing Organization (CDMO) Advance a Cell & Gene Therapy Product?

  Making the Decision to Engage a CDMO

Tell us what you thought about this post.